Search

everythinglearnresearchcommunity

for

Search:↓

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The document explains various skin conditions and their treatments.

The document explains different types of skin lesions and their characteristics, causes, and related conditions.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Different stages and types of female hair loss are linked with age, menopause, high blood pressure, and skin conditions like acne and hirsutism.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Women with high androgen levels may have more severe COVID-19 symptoms.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Anabolic steroid users may face higher risk of severe COVID-19.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.